ÂÜÀòÂÒÂ×

Nadia Ladygina is an experienced scientist currently serving as Principal Scientist at AnaptysBio since February 2023, with previous roles as Associate Director at Replay and Senior Principal Scientist at Bristol Myers Squibb. Academic training includes a PhD in Molecular and Cellular Biology from Fox Chase Cancer Center and multiple medical and biochemistry degrees from Russian State Medical University. Professional expertise encompasses the development of assays and inhibitor characterization, along with significant contributions to target validation and T cell research through innovative techniques in various research institutions such as Johnson & Johnson, La Jolla Institute for Allergy and Immunology, and Cleveland Clinic. Throughout a career that began with a PhD and spans over two decades, Nadia has led and contributed to numerous impactful projects in the fields of immunology and cancer research.